Anti-Fungal Drugs Market to grow at a CAGR of 10.39% during the forecast period
Increase in research and
development activities and growing healthcare infrastructure are expected to
drive the global anti-fungal drugs market in the forecast period.
According to TechSci Research report, “Global Anti-Fungal
Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines,
Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis,
Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection,
Systemic Fungal Infection), By Route of Administration (Topical, Oral,
Parenteral, Others), By End-User (Homecare, Hospitals, Clinics, Others) By
Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By
Region, Competition Forecast & Opportunities, 2026”, the global
anti-fungal drugs market is
expected to reach USD28484.69 million by 2026 and to grow with a CAGR of 10.39%
during the forecast period. Anti-fungal
drugs are in high demand as they identify the presence of fungal pathogens
residing in the body and eliminate the pathogens rendering minimal side-effects
to the body. The unhygienic and unclean environment is the most preferable spot
for the fungus generation. These fungi grow by multiplying themselves by
spreading the spores which subsequently lead to infection on the skin or can be
spread by inhaling and these are called systemic fungal infections.
The COVID-19 outbreak across the world which has been
declared as a pandemic by the World Health Organization has affected several
countries adversely. Leading authorities around the world imposed lockdown and
released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus-affected patients started suffering from shortness of
breath along with coughing and sneezing. Leading authorities of several nations
increased the capacity of hospitals as a huge number of patients were getting
affected daily and getting admitted into the hospitals. Due to the imposition
of strict lockdown restrictions, disruption in the supply chain was observed.
Import and export activities were stopped which led to the shortage of raw
materials and finished medical supplies and drugs. However, post COVID-19
period coupled with relaxation offered by leading authorities is expected to
fuel the market growth in the forecast period.
However, side-effects of anti-fungal drugs and the
presence of counterfeit drugs may create hindrance to the growth of the global
antifungal drugs market.
Browse 225 Figures spread through 110 Pages and an
in-depth TOC on "Global Anti-Fungal Drugs Market”.
https://www.techsciresearch.com/report/anti-fungal-drugs-market/7786.html
The
global anti-fungal drugs market is segmented into drug class, indication,
infection type, route of administration, end-user, distribution channel,
regional distribution, and company. Based on drug class, the market can be
divided into azoles, echinocandins, polyenes, allylamines, and others. The
Azoles segment is expected to hold a major market share in the forecast period,
2022-2026. Azoles are synthetic and semi-synthetic compounds that are used for
invasive and superficial fungal infections. Azole drugs are available in
different formulations including tablets, capsules, cream, vaginal cream, and
lotion. These drugs are in high demand for treatment of athlete’s foot, yeast
infection, candidiasis, aspergillosis, among other fungal infections. Azole
drugs are considered safe as they cause lesser side effects and have lower
interactions with other drugs. The azole group offers a wide range of
activities and has enhanced absorption and digestion properties which is the
major reason for the high demand of this segment. Based on indication, the
global anti-fungal drugs market can be divided into mucormycosis,
dermatophytosis, aspergillosis, candidiasis, and others. The candidiasis
indication type is expected to dominate the anti-fungal drugs market for the
next five years. An increase in the occurrence of candida infections among various
populations is the major driver for this segment. Adoption of unhealthy lifestyles
including consumption of junk foods and growing preference for sedentary
lifestyle is also leading to a surge in the demand for this segment. Astellas
Pharma Inc., GlaxoSmithKline Plc, Abbott Laboratories Ltd., Bayer AG, Dr.
Reddy's Laboratories Ltd., Gilead Sciences Inc., Janssen Pharmaceuticals Inc.
(Johnson & Johnson), Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Teva
Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Sun
Pharmaceuticals Industries Ltd., Lupin Ltd., Zydus Cadila Ltd. are the leading
players operating in the global anti-fungal drugs market. Manufacturers are
increasingly focusing on the research and development process to fuel higher
growth in the market. To meet evolving customer demand with respect to better
efficiency and durability, several anti-fungal drugs manufacturers are coming
up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7786
Customers can also
request for 10% free customization on this report.
“Market
players are investing huge amounts to use advanced formulation techniques to
develop advanced anti-fungal drugs. Nanotechnology is an advanced technique to
improve the outcome of drug consumption. The launch of novel advanced products
using nanostructured drug delivery systems to ensure effective treatment of
vaginal and oral candidiasis is expected to contribute to high market demand in
the next five years. Also, the growing occurrence of target diseases such as
cancer which weakens the immune system of the human body is further anticipated
to propel the global anti-fungal drugs market till 2026” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Global
Anti-Fungal Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines,
Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis,
Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection,
Systemic Fungal Infection), By Route of Administration (Topical, Oral,
Parenteral, Others), By End-User (Homecare, Hospitals, Clinics, Others) By
Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By
Region, Competition Forecast & Opportunities, 2026” has
evaluated the future growth potential of global anti-fungal drugs market and provided
statistics & information on market size, shares, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in the of global anti-fungal drugs market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web:
https://www.techsciresearch.com/